Copyright: ©Author(s) 2026.
World J Diabetes. Oct 15, 2026; 17(10): 124847
Published online Oct 15, 2026. doi: 10.4239/wjd.124847
Published online Oct 15, 2026. doi: 10.4239/wjd.124847
Table 1 Methods for diagnostic criteria by different working groups
| Ref. | Muscle mass | Muscle strength | Physical performance |
| Cruz-Jentoft et al[7], EWGSOP2 | DXA (ALM/height2): Male < 7.00 kg/m2, female < 6.00 kg/m2 or CT or BIA or MRI | Grip strength: Male < 27 kg, female < 16 kg | Gait speed: < 0.8 m/second or SPPB: ≤ 8 or TUG: ≥ 20 seconds |
| Bhasin et al[8], SDOC | Not specified | Grip strength: Male < 35.5 kg, female < 20 kg | Gait speed: < 0.8 m/second |
| Chen et al[9], AWGS | DXA (ASM): Male < 7.0 kg/m2, female < 5.4 kg/m2 or BIA (ASM): Male ≤ 7.0 kg/m2, female < 5.7 kg/m2 | Grip strength: Male < 28 kg, female < 18 kg | Gait speed (6 m): < 1.0 m/second or 5 times stand-to-sit test: > 12 seconds or SPPB: ≤ 9 |
| Fielding et al[10], IWGS | DXA (ALM/height2): Male < 7.23 kg/m2, female < 5.67 kg/m2 | Not specified | Gait speed (4 m): < 1.0 m/second or standing up from a chair |
| Studenski et al[11], FNIH | DXA (ALM/BMI): Male < 0.789 kg/BMI, female < 0.512 kg/BMI | Grip strength: Male < 26 kg, female < 16 kg | Gait speed (4 m), gait speed (6 m): < 0.8 m/second |
Table 2 Studies on the effect of nutritional intervention on sarcopenia in type 2 diabetes mellitus
| Nutrition intervention | Study design | Target population | Age (years old) | Research objectives | Results | Ref. |
| Vitamin intake | Prospective cohort study | T2DM patients | ≥ 65 | Loss of muscle mass | Vitamin D intake is associated | Takahashi et al[92] |
| Protein intake | Cross-sectional | T2DM patients | ≥ 31 | Muscle loss | Negative impact | Fanelli et al[151] |
| Protein supplementation | Randomized controlled study | T2DM patients | > 55 | Physical performance and body composition | Positively improved | Argyropoulou et al[152] |
| BCAAs | Longitudinal study | T2DM patients | 56.6 ± 10.6 | Skeletal muscle loss | Negatively associated | Low et al[153] |
| Medical nutrition therapy | prospective study | T2DM patients | 74 ± 6.0 | Handgrip strength | Effective | Gaglio et al[154] |
| Omega-3 fatty acids intake | Cross-sectional | T2DM patients | 74.2 ± 5.7 | Sarcopenia | Negatively associated | Okamura et al[155] |
| BCAAs | Randomized controlled study | T2DM patients | 65-80 | Skeletal muscle mass | No significant correlation | Matsuda et al[156] |
| Exercise and protein intake | Cohort study | T2DM patients | ≥ 65 | Decreasing skeletal muscle mass index | Negatively associated | Hashimoto et al[157] |
| Resistance training and nutritional interventions | Prospective cohort study | Frail T2DM patients | 79 ± 5.6 | SPPB, maximal strength and power output | Positively improved | Izquierdo et al[158] |
Table 3 Studies on the effect of physical exercise on sarcopenia with T2DM
| Physical exercise intervention | Study design | Duration | Target population | Research objectives | Results | Ref. |
| Low-volume walking high-intensity interval training | Randomized controlled trial | 12 weeks | Older women with T2DM | Cardiovascular risk profile and physical capacity | Significantly improved | Marcotte-Chénard et al[159] |
| ST, aerobic training | Randomized, controlled trial | 9 months | Normal-weight T2DM | HbA1c level and body composition | ST – significantly improved outcomes and increased lean body mass | Kobayashi et al[160] |
| Progressive sandbag exercise training | Randomized, controlled trial | 12 weeks | Patients with T2DM and possible sarcopenia | HbA1c levels, muscle strength, and physical performance | Significantly improved | Chien et al[78] |
| Resistance exercise | Own-controlled before-and-after cohort study | 24 hours | Older patients with T2DM and sarcopenia | Blood glucose | Lower blood glucose | Zhao et al[161] |
| In-Hospital exercise rehabilitation | Randomized, controlled trial | 12 weeks | Middle-aged and elderly patients with T2DM and sarcopenia | Blood glucose, lipids, and muscle strength | Effectively improve | Shi et al[162] |
- Citation: Xie XL, Cao HY, Wang ZT, Chen HR, Zhou LS, Qian T, Han ZY. Pathophysiological mechanisms and risk factors linking type 2 diabetes mellitus and sarcopenia: A narrative review. World J Diabetes 2026; 17(10): 124847
- URL: https://www.wjgnet.com/1948-9358/full/v17/i10/124847.htm
- DOI: https://dx.doi.org/10.4239/wjd.124847